Hide Message

Updating the Resource Centre Digital Platform

The Business & Human Rights Resource Centre is at a critical point in its development. Our digital platform is home to a wealth of information on business and human rights, but hasn’t had a visual refresh for a number of years.

We will soon be updating the site to improve its usability and better serve the thousands of people that use our site to support their work.

Please take an advance peek at our new look, and let us know what you think!

Thank you,
Alex Guy, Digital Officer

Find Out More Hide Message

Pfizer to pay $430 million for false drug marketing

Author: Lisa Richwine, Reuters, Published on: 13 May 2004

Pfizer has agreed to pay $430 million (245 million pounds) and plead guilty to criminal charges for illegally marketing an epilepsy drug for unapproved uses such as migraines and pain, U.S. prosecutors say...The company's Warner-Lambert division promoted the drug, Neurontin, for uses it had no scientific evidence to support...[also refers to TAP Pharmaceuticals (joint venture Abbott Laboratories & Takeda Chemical Industries)]

Read the full post here

Related companies: Abbott Laboratories Pfizer Takeda Pharmaceutical TAP Pharmaceuticals (joint venture Abbott Laboratories & Takeda Pharmaceutical) Warner-Lambert (part of Pfizer)